Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Medical Oncology|July 20, 2018
Frequency, impact and a preclinical study of novel <i>ERBB</i> gene family mutations in HER2-positive breast cancerNaomi Elster, Sinead Toomey, Yue Fan, et al.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Breast Cancer Research : BCR|July 29, 2017
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapiesSinead Toomey, Alexander J Eustace, Joanna Fay, et al.
NPJ Genomic Medicine|May 29, 2024
Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patientsTom Venken, Ian S Miller, Ingrid Arijs, et al.
Plos One|December 18, 2020
Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trialLauren Brady, Brian Hayes, Gráinne Sheill, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 22, 2023
ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancerGráinne Sheill, Lauren Brady, Brian Hayes, et al.
Cancers|July 10, 2020
Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerSinead Toomey, Jillian Gunther, Aoife Carr, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
Journal of Translational Medicine|February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samplesSinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Cancers|September 28, 2021
Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)Brian Hayes, Lauren Brady, Gráinne Sheill, et al.
Pageof 6